Clinical Trial Update: Ganoderma Spores Modulate the Gut-Brain Axis [NA]

View source ↗

Summary

A not-yet-recruiting clinical trial is evaluating Ganoderma spores as a potential modulator of the gut-brain axis in depression and thyroid cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Thyroid Cancer

Drugs mentioned

• Ganoderma spores (Ganoderma lucidum spores)

Snippet

Sponsor: Ling Zhiqiang | Conditions: Depression, Thyroid Cancer | NA | Status: NOT_YET_RECRUITING